Work

Association of clinical parameters and overall survival (OS) in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with high-dose interleukin-2 (HD IL-2).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.476

Authors: David D. Stenehjem, Kinjal Parikh, Julia Anne Batten, Joan Van Atta, Hilda Crispin, Daniel S. Sageser, Kenneth F. Grossmann, Junfeng Wang, Srinivas Kiran Tantravahi, Wolfram E. Samlowski, Neeraj Agarwal

Institutions: University of Utah, Huntsman Cancer Institute, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591056554

Cites:

Cited by:

Related to: 10